These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 6497495)

  • 1. [Pathogenesis of acute myocardial infarction. I. Complement activation in vivo and development of infarction].
    Reyes PA; Fernández de la Reguera G; Enríquez C
    Arch Inst Cardiol Mex; 1984; 54(4):327-32. PubMed ID: 6497495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement activation in acute coronary syndromes.
    Iltumur K; Karabulut A; Toprak G; Toprak N
    APMIS; 2005 Mar; 113(3):167-74. PubMed ID: 15799759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Complement system proteins in the acute phase of myocardial infarction].
    Gukasian IA; Kovanov VV; Khil'kin AM; Shmelev IA
    Vopr Med Khim; 1980; 26(3):362-5. PubMed ID: 7456367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response in acute coronary syndromes.
    Jan V; Jalal S; Aslam K; Iqbal K; Tramboo N; Alai MS; Rather H; Lone N
    Indian Heart J; 1999; 51(5):515-20. PubMed ID: 10721642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local complement activation triggers neutrophil recruitment to the site of thrombus formation in acute myocardial infarction.
    Distelmaier K; Adlbrecht C; Jakowitsch J; Winkler S; Dunkler D; Gerner C; Wagner O; Lang IM; Kubicek M
    Thromb Haemost; 2009 Sep; 102(3):564-72. PubMed ID: 19718478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial changes of complement titers in the acute phase of myocardial infarction.
    Imai T; Takase S; Arai M; Fujita T
    Jpn Circ J; 1983 Mar; 47(3):289-93. PubMed ID: 6834639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of complement in the skin after PUVA therapy.
    Clemmensen OJ; Staberg B; Worm AM
    Acta Derm Venereol; 1984; 64(1):5-8. PubMed ID: 6203282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of C1-esterase inhibitor during emergency coronary artery bypass surgery in acute ST-elevation myocardial infarction.
    Thielmann M; Marggraf G; Neuhäuser M; Forkel J; Herold U; Kamler M; Massoudy P; Jakob H
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):285-93. PubMed ID: 16829095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolytic treatment and complement activation.
    Agostoni A; Gardinali M; Frangi D; Cugno M; Cafaro C; Conciato L; Sponzilli C; Salmoirago E
    Ann Ital Med Int; 1994; 9(3):178-9. PubMed ID: 7946896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study.
    Engström G; Hedblad B; Janzon L; Lindgärde F
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):392-7. PubMed ID: 17568238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The complement system in the acute phase of myocardial infarction.
    Yasuda M; Kawarabayashi T; Akioka K; Teragaki M; Oku H; Kanayama Y; Takeuchi K; Takeda T; Kawase Y; Ikuno Y
    Jpn Circ J; 1989 Sep; 53(9):1017-22. PubMed ID: 2513427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H.
    Pickering MC; Cook HT; Warren J; Bygrave AE; Moss J; Walport MJ; Botto M
    Nat Genet; 2002 Aug; 31(4):424-8. PubMed ID: 12091909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of serum C3 levels with the risk of myocardial infarction.
    Muscari A; Bozzoli C; Puddu GM; Sangiorgi Z; Dormi A; Rovinetti C; Descovich GC; Puddu P
    Am J Med; 1995 Apr; 98(4):357-64. PubMed ID: 7709948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation of hepatic necrosis and complement system activation in fulminant viral hepatitis].
    Hou J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Feb; 15(1):49-54. PubMed ID: 8324837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibitory effect of selenium on complement activation and its clinical significance].
    Hou JC; Jiang ZY; He ZF
    Zhonghua Yi Xue Za Zhi; 1993 Nov; 73(11):645-6, 699. PubMed ID: 7907268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity in electrophoretic mobility of C3-derived molecules expressing D but not C-epitopes following in vivo activation of the complement system.
    Teisner B; Brandslund I; Hau J; Svehag SE
    Acta Pathol Microbiol Immunol Scand C; 1983 Feb; 91(1):85-7. PubMed ID: 6191520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The analysis of the complement activation product SC5 b-9 is applicable in neonates in spite of their profound C9 deficiency.
    Høgåsen AK; Overlie I; Hansen TW; Abrahamsen TG; Finne PH; Høgåsen K
    J Perinat Med; 2000; 28(1):39-48. PubMed ID: 10765513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum beta1A/C-globulin level in early myocardial infarction.
    Füst G; Surján M; Braun P; Várkonyi S
    Acta Med Acad Sci Hung; 1975; 32(1):49-54. PubMed ID: 1233860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Specific measurement of alternate pathway activation of complement in human glomerulonephritides (GN): 125 cases (author's transl)].
    Berthoux FC; Freyria AM
    Nephrologie; 1980; 1(2):61-6. PubMed ID: 7301022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemolytic anemia, myocardial infarction and xenotransplantation: what do they have in common?].
    Schifferli JA
    Schweiz Med Wochenschr; 1995 Nov; 125(46):2217-25. PubMed ID: 8525341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.